Small molecule ectonucleotidase inhibitors for the immunotherapy of cancer

被引：0
|
作者：
Muller, Christa [1 ,2 ]
机构：
[1] Univ Bonn, Pharmaceut Chem, Bonn, Germany
[2] PharmaCtr Bonn, Bonn, Germany
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 257卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
2
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Small Molecule CDK Inhibitors for the Therapeutic Management of Cancer
    Goel, Bharat
    Tripathi, Nancy
    Bhardwaj, Nivedita
    Jain, Shreyans K.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2020, 20 (17) : 1535 - 1563
  • [32] Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer
    Vigano, Mauro
    La Milia, Marta
    Grassini, Maria Vittoria
    Pugliese, Nicola
    De Giorgio, Massimo
    Fagiuoli, Stefano
    CANCERS, 2023, 15 (06)
  • [33] Progress towards orally bioavailable, potent, and selective small-molecule inhibitors of CD73 for cancer immunotherapy
    Lindsey, E.
    Lawson, K.
    Thomas-Tran, R.
    Beatty, J.
    Fournier, J.
    Mandal, D.
    Yan, X.
    Drew, S.
    Jeffrey, J.
    Walker, N.
    Straeter, N.
    Moschuetz, S.
    Chen, A.
    Tan, J.
    Jin, L.
    Walters, M.
    Young, S.
    Schindler, U.
    Leleti, M.
    Powers, J.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E93 - E93
  • [34] Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017-present)
    Nocentini, Alessio
    Capasso, Clemente
    Supuran, Claudiu T.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2021, 31 (10) : 867 - 876
  • [35] Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy
    Masci, Domiziana
    Puxeddu, Michela
    Silvestri, Romano
    La Regina, Giuseppe
    MOLECULES, 2024, 29 (09):
  • [36] Evaluation of STK17B as a cancer immunotherapy target utilizing highly potent and selective small molecule inhibitors
    Scheuplein, Felix
    Renner, Florian
    Campbell, John E.
    Campbell, Robert
    De Savi, Chris
    Eckmann, Jan
    Fischer, Holger
    Ge, Jie
    Green, Luke
    Jakob, Peter
    Kim, Joseph L.
    Kinkema, Caitlin
    McGinn, Katie
    Medina, Ricardo
    Mueller, Annemarie
    Perez, Nisha
    Perola, Emanuele
    Timsit, Yoav
    Traore, Tary
    Hopfer, Ulrike
    Tyanova, Stefka
    Tzouros, Manuel
    Wang, Ruduan
    Woessner, Richard
    Dorsch, Marion
    Bischoff, James R.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [37] Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancer
    Adderley, H.
    Blackhall, F. H.
    Lindsay, C. R.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (03) : 589 - 595
  • [38] Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancer
    H. Adderley
    F. H. Blackhall
    C. R. Lindsay
    Cancer Immunology, Immunotherapy, 2021, 70 : 589 - 595
  • [39] High-affinity small molecule inhibitors of T cell costimulation: Compounds for immunotherapy
    Huxley, P
    Sutton, DH
    Debnam, P
    Matthews, IR
    Brewer, JE
    Rose, J
    Trickett, M
    Williams, DD
    Andersen, TB
    Classon, BJ
    CHEMISTRY & BIOLOGY, 2004, 11 (12): : 1651 - 1658
  • [40] A case for combining immunotherapy and targeted small molecule inhibitors: Immunoregulation by primary melanoma cells
    Maniyar, Rachana R.
    Chakraborty, Sanjukta
    Tuli, Neha Y.
    Ben Rahoma, Ghada
    Singh, Sarnath
    Wallack, Marc
    Geliebter, Jan
    Tiwari, Raj K.
    CANCER RESEARCH, 2018, 78 (13)
12345